Grappling with hand and foot atopic dermatitis

Dr Linda Stein Gold and Dr Jonathan Silverberg discuss atopic dermatitis of the hands and feet, including its multidimensional burden on quality of life.

Many people with hand and foot atopic dermatitis have bleeding fissures from uncontrolled dermatitis, meaning daily activities, such as washing dishes or wearing socks/shoes, are incredibly challenging, and, in the case of hand dermatitis, they feel embarrassed by the appearance of their hands

Episode 1: Getting to grips with atopic dermatitis of the hands and feet: What is it, and what does it mean for patients? 

Dr Linda Stein Gold and Dr Jonathan Silverberg discuss the epidemiology, clinical presentation and classification of atopic dermatitis of the hands and feet. What impact does it have on patients’ quality of life and how can we effectively measure this?

Episode 2: First-hand experience: Practical insights on the diagnosis and assessment of atopic dermatitis of the hands and feet

Dr Linda Stein Gold and Dr Jonathan Silverberg consider the challenges associated with the diagnosis of atopic dermatitis of the hands and feet and tools for assessing disease severity in clinical practice. What tools are available and how can they be used in the clinic?

Meet the experts

Dr Linda Stein Gold

Dr Linda Stein Gold is Director of Dermatology Clinical Research for the Henry Ford Health System in Detroit, Michigan, and Division Head of Dermatology for the Henry Ford Health System in West Bloomfield, Michigan, USA. Her recent research has focused on treatments for atopic dermatitis, rosacea, acne, psoriasis, seborrheic dermatitis, alopecia areata and actinic keratoses.

Disclosures: Investigator/advisor and/or speaker for AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Dermavant, Incyte, LEO Pharma, Pfizer, Regeneron, and Sanofi.

Dr Jonathan Silverberg

Dr Jonathan Silverberg is a Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, USA. He is the Director of Clinical Research and Contact Dermatitis. Dr Silverberg’s area of clinical subspecialty is inflammatory skin disease, particularly atopic and contact dermatitis. He is also a national expert in allergy patch testing, phototesting and photopatch testing. Dr Silverberg’s research interests include the epidemiology of chronic and infectious diseases.

Disclosures: Honoraria as a consultant and/or advisory board member for AbbVie, Alamar, Aldena Therapeutics, Amgen, AOBiome, Apollo Pharma, Arcutis, Arena Pharmaceuticals, Asana, ASLAN Pharmaceuticals, Attovia, BiomX, Biosion, Bodewell, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celgene, Connect Biopharma, CorEvitas, Dermavant, FIDE, Galderma, GSK, Incyte, Invea, Kiniksa, LEO Pharma, Lilly, Merck, MyOr Diagnostics, Nektar, Novartis, Optum, Pfizer, RAPT Therapeutics, Recludix, Regeneron, Sandoz, Sanofi-Genzyme, Shaperon, Target RWE, Teva, UNION, and UpToDate. Speaker for AbbVie, LEO Pharma, Lilly, Pfizer, Regeneron, and Sanofi-Genzyme. Institution received grants from Galderma, Incyte, and Pfizer. 

More information at ADVENTprogram.com